title: Systematic review: Endoscopic dilatation in Crohn's disease.
abstract: BACKGROUND
  Endoscopic dilatation for Crohn's disease has been evaluated only in some small and heterogeneous studies.
  
  
  OBJECTIVE
  To evaluate any association between the main clinical variables and endoscopic variables and the efficacy and safety of endoscopic dilatation in Crohn's disease.
  
  
  METHODS
  A Medline search regarding pneumatic dilatation in Crohn's disease was performed. Several technical and clinical variables were extracted from each study to build up a descriptive, pool-data analysis. Data on individual patients were extracted from suitable studies to create a simulated population upon which a multivariate statistical analysis was performed.
  
  
  RESULTS
  Thirteen studies enrolling 347 Crohn's disease patients were reviewed. Endoscopic dilatation was mainly applied to postsurgical strictures, being technically successful in 86% of the cases. Long-term clinical efficacy was achieved in 58% of the patients. Mean follow-up was as long as 33 months, corresponding to 800 patient years of follow-up. Major complication rate was 2%, being higher than 10% in two series. At multivariate analysis, a stricture length < or = 4 cm was associated with a surgery-free outcome (OR: 4.01; 95% CI: 1.16-13.8; P < 0.028).
  
  
  CONCLUSIONS
  Endoscopic dilatation is an effective and safe treatment for short strictures caused by Crohn's disease, impacting substantially on the natural history of these patients.
authors: Gastroenterology and Digestive Endoscopy Unit, Nuovo Regina Margherita Hospital, Rome, Italy. cesareh@hotmail.com
authors: C
authors: C
authors: Hassan
authors: A
authors: A
authors: Zullo
authors: V
authors: V
authors: De Francesco
authors: E
authors: E
authors: Ierardi
authors: M
authors: M
authors: Giustini
authors: A
authors: A
authors: Pitidis
authors: F
authors: F
authors: Taggi
authors: S
authors: S
authors: Winn
authors: S
authors: S
authors: Morini
mesh_terms: D002404:Catheterization / Q000009:adverse effects / Q000379:methods*; D003251:Constriction, Pathologic / Q000628:therapy; D003424:Crohn Disease / Q000628:therapy*; D016099:Endoscopy, Gastrointestinal / Q000009:adverse effects / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged